54.7 F
June 17, 2024
PI Global Investments
Private Equity

Goodwin Recognized as a Leading Firm in Asia for Private Equity, Private Investment Funds, M&A and Life Sciences | News & Events

Goodwin’s Asia practice was recognized for their market-leading work in 2024 by Chambers Asia Pacific, Chambers Greater China Region, and The Legal 500 Asia Pacific. Goodwin received practice rankings across geographies including Asia-Pacific, China, Hong Kong SAR, Singapore, and India, and several Goodwin partners were named as leading lawyers.

Goodwin’s standout practice rankings in Chambers and Legal 500 for 2024 include:

Chambers Asia Pacific

  • Corporate/M&A: Private Equity (Asia-Pacific)
  • Investment Funds: Private Equity (Asia-Pacific)
  • Corporate/M&A (India)
  • Investment Funds: International (Singapore)

Chambers Greater China Region

  • Private Equity: Buyouts & Venture Capital Investment
  • Investment Funds – Private Equity
  • Life Sciences

The Legal 500 Asia Pacific

  • Private Equity (Hong Kong)
  • Private Equity (China)
  • Corporate (including M&A) (Hong Kong)
  • Investment Funds (Hong Kong)
  • Investment Funds (Singapore)

Goodwin lawyers ranked by Chambers and/or Legal 500 include:

  • Yash Rana – Corporate M&A (India), Private Equity: Buyout & Venture Capital Investment (China)
  • Douglas Freeman – Private Equity: Buyout & Venture Capital Investment (China)
  • Daniel Dusek – Corporate/M&A (China), Private Equity: Buyout & Venture Capital Investment (China), Private Equity (Hong Kong), Corporate (including M&A) (Hong Kong)
  • Victor Chen – Private Equity: Buyout & Venture Capital Investment (China)
  • Abhishek Krishnan – Corporate M&A (India)
  • Gregory Barclay – Investment Funds: International (Singapore)
  • Matthew Nortcliff – Investment Funds: International (Singapore), Investment Funds (Singapore)
  • Wendy Pan – Life Sciences (China)
  • Stephen Howard – Banking & Finance (Hong Kong)

The Goodwin Asia team received high praise from clients across the firm’s core practice areas, with sources noting that:

  • Private Equity/Corporate M&A – “The partners are exceptionally knowledgeable about the various markets and are brilliant. They have done a wonderful job building a solid base to have the volume and expertise.”
  • Investment Funds – “The team is very sophisticated in fund formation and fundraising. The lawyers are attentive and responsive, and they always react to our request quickly.”
  • Life Sciences – “They go beyond in working through the deliverables to explain how each section approaches the key issues and identifying areas where discussion and compromise may be warranted.”

To view all of Goodwin’s 2024 rankings, visit Chambers Asia Pacific, Chambers Greater China Region, and The Legal 500 Asia Pacific.

Source link

Related posts

Private equity investments in Middle East plunge to 3-year low


Fostering Growth And Global Impact With Edward Chang


Alvarez & Marsal, Pactio: Transforming Private Equity Deals


Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.